1Desmond DM,Moroney JT,Begiella E,et al.Dementia as a predictor of adverse outcomes following stroke: An valuation of diagnostic methods[].Stroke.1998
2Arai H,Claik CM,Ewbank DC.Cerebrospinal fluid tau protein in Alzheimer’ s disease and prion-related encephalopathies studies with synthetic[].Progress in Neurobiology.1996
3Nitsch RM,Rcaccr GW,Deng M,et al.Cerebrospinal fluid levels of amyloid -protein in Alzheimer’ s disease: Inverse correlation with severity of dementia and effect of apolipoprotein E genotype[].Annals of Neurology.1995
4Borth W.2-Macroglobulin, a multifunctional binding protein with targeting characteristics[].The FASEB Journal.1992
5Lauer R.2-macroglobulin-mediated degradation of amyloid 1-42:Amechanism to enhance amyloid catabolism[].Experimental Neurology.2001
6Qiu W,Borth W,Ye Z,et al.Degradation of amyloid -protein by a serineprotease- 2-macroglobulin complex[].Journal of Biological Chemistry.1996
7Zappia M,Cittadella R,Mannal I,et al.Genetic association of 2macroglobulin polymorphisms with AD in southern Italy[].Neurology.2002
8Yan SD,Chen X,Fu J,et al.RAGE and amyloid-Bepetide neonotoxicityin Alzheimer’ s disease[].Nature.1996
9Troy CM,Rabacchi SA,Friedman WJ,et al.Caspase-2 mediates neuronal cell death induced by beta-amyloid[].The Journal of Neuroscience.2000
10Tanabe Y,Ishizo H,Ishigoro K,et al.Tau pathology in diffuse neurofibrillary tangles with lcification ( DNTC ): Biochemical and immunohistochemical investigation[].NeuroReport.2000
